- Home
- YMM vs EXAS Comparison
YMM vs EXAS Comparison
Compare YMM & EXAS Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- YMM
- EXAS
- Stock Information
- Founded
- YMM 2011
- EXAS 1995
- Country
- YMM China
- EXAS United States
- Employees
- YMM N/A
- EXAS N/A
- Industry
- YMM Computer Software: Prepackaged Software
- EXAS Medical Specialities
- Sector
- YMM Technology
- EXAS Health Care
- Exchange
- YMM Nasdaq
- EXAS Nasdaq
- Market Cap
- YMM 12.3B
- EXAS 11.0B
- IPO Year
- YMM 2021
- EXAS N/A
- Fundamental
- Price
- YMM $13.08
- EXAS $66.98
- Analyst Decision
- YMM Buy
- EXAS Strong Buy
- Analyst Count
- YMM 3
- EXAS 20
- Target Price
- YMM $13.00
- EXAS $68.20
- AVG Volume (30 Days)
- YMM 6.5M
- EXAS 2.3M
- Earning Date
- YMM 11-17-2025
- EXAS 11-03-2025
- Dividend Yield
- YMM 1.48%
- EXAS N/A
- EPS Growth
- YMM 64.18
- EXAS N/A
- EPS
- YMM 0.55
- EXAS N/A
- Revenue
- YMM $1,695,281,415.00
- EXAS $2,939,949,000.00
- Revenue This Year
- YMM $6.27
- EXAS $16.68
- Revenue Next Year
- YMM $6.98
- EXAS $12.36
- P/E Ratio
- YMM $23.65
- EXAS N/A
- Revenue Growth
- YMM 25.14
- EXAS 12.55
- 52 Week Low
- YMM $8.20
- EXAS $38.81
- 52 Week High
- YMM $14.07
- EXAS $72.83
- Technical
- Relative Strength Index (RSI)
- YMM 53.65
- EXAS 77.44
- Support Level
- YMM $12.40
- EXAS $62.39
- Resistance Level
- YMM $13.40
- EXAS $65.44
- Average True Range (ATR)
- YMM 0.35
- EXAS 1.67
- MACD
- YMM 0.03
- EXAS -0.02
- Stochastic Oscillator
- YMM 70.45
- EXAS 95.16
About YMM Full Truck Alliance Co. Ltd. (each representing 20)
Full Truck Alliance Co Ltd, through its subsidiaries, provides comprehensive services for shippers and truckers through its mobile and website platforms. Its principal operations are in the People's Republic of China. The group derives its revenues principally from shippers and trucker's use of its platforms in connection with freight matching services and value-added services.
About EXAS Exact Sciences Corporation
Exact Sciences, headquartered in Madison, Wisconsin, provides cancer screening and diagnostic test products in the United States and internationally. Exact's Cologuard screening test is a noninvasive stool-based DNA test for colorectal cancer. The company also competes in the precision oncology market with Oncotype DX, a suite of tissue-based genomic tests for estimating recurrence risk and likelihood of benefit from chemotherapy for breast and colon cancer, and OncoExTra, a liquid-based comprehensive genomic profiling test. It also has a pipeline of blood-based tests for molecular residual disease, colorectal cancer screening, and multicancer screening.